ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response.
We look at cold, immune-excluded tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 2450 Holcombe Blvd,
- Phone
- 346-772-0336
- in****@****sis.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- immunogenesis.com
- Keywords
- Manager jobs.
- HQ
- Houston, Texas
Immunogenesis, Inc. Questions
Immunogenesis, Inc.'s helpline number is 346-772-0336
Immunogenesis, Inc.'s website is immunogenesis.com
Immunogenesis, Inc.'s LinkedIn profile is https://www.linkedin.com/company/immunogenesis-inc
Immunogenesis, Inc. has
14 employees.
View email and phone details for 14
employees at Immunogenesis, Inc..
Immunogenesis, Inc.'s industry is
Biotechnology Research
Immunogenesis, Inc.'s top competitors are
Mongoose Bio Inc.,
Taurus Vascular,
Case45,
Geneos Therapeutics,
Rua Diagnostics,
March Biosciences,
Lindonlight Collective,
Cytoagents, Inc,
Inovio Pharmaceuticals, Inc.,
Biohouston.
Immunogenesis, Inc.'s support email address is info@immunogenesis.com
Immunogenesis, Inc.'s categories are Biotechnology Research
Immunogenesis, Inc.'s founding year is 2019
